Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03838874 · ClinicalTrials.gov registry record · Phase 2
Mepivacaine Versus Low-Dose Bupivacaine For Primary Total Hip and Knee Arthroplasty
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 154
- Enrollment target
NCT03838874: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT03838874 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 154 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03838874, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 154 participants
- Enrollment target
Study Summary
This research is being done to see if there is a difference between two different spinal anesthetics (Mepivacaine vs. Bupivacaine) as it relates to reducing post-operative complications and the time it takes for subjects to regain mobility after surgery.
Interventions
- DRUG Mepivacaine
- DRUG Low-Dose Bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2019-02-25 |
| Est. Completion | 2019-10-29 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03838874
The ClinicalTrials.gov registry entry for NCT03838874 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mepivacaine is the first listed.
NCT03838874 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03838874 about?
NCT03838874 is a clinical study titled "Mepivacaine Versus Low-Dose Bupivacaine For Primary Total Hip and Knee Arthroplasty". This research is being done to see if there is a difference between two different spinal anesthetics (Mepivacaine vs. Bupivacaine) as it relates to reducing post-operative complications and the time it takes for subjects to regain mobility after surgery.
What is the current status of trial NCT03838874?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 154 participants. The study started on 2019-02-25. Estimated completion is 2019-10-29.
What interventions are being tested in trial NCT03838874?
The interventions under investigation include: Mepivacaine (DRUG), Low-Dose Bupivacaine (DRUG).
Who is sponsoring clinical trial NCT03838874?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.